IFM Investors Pty Ltd purchased a new position in shares of Teleflex Incorporated (NYSE:TFX) in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 1,398 shares of the medical technology company’s stock, valued at approximately $338,000.

A number of other hedge funds also recently modified their holdings of the stock. Janus Henderson Group PLC grew its stake in Teleflex by 50,429.2% during the second quarter. Janus Henderson Group PLC now owns 1,816,020 shares of the medical technology company’s stock worth $377,296,000 after buying an additional 1,812,426 shares during the period. Koch Industries Inc. grew its stake in Teleflex by 47,174.3% during the second quarter. Koch Industries Inc. now owns 959,669 shares of the medical technology company’s stock worth $955,000 after buying an additional 957,639 shares during the period. American Century Companies Inc. grew its stake in Teleflex by 41.6% during the third quarter. American Century Companies Inc. now owns 1,187,909 shares of the medical technology company’s stock worth $287,438,000 after buying an additional 348,829 shares during the period. Marshall Wace North America L.P. grew its stake in Teleflex by 137.4% during the second quarter. Marshall Wace North America L.P. now owns 518,462 shares of the medical technology company’s stock worth $107,840,000 after buying an additional 300,069 shares during the period. Finally, Principal Financial Group Inc. grew its stake in Teleflex by 93.5% during the second quarter. Principal Financial Group Inc. now owns 610,398 shares of the medical technology company’s stock worth $126,816,000 after buying an additional 294,935 shares during the period. 89.31% of the stock is owned by hedge funds and other institutional investors.

Several research firms have issued reports on TFX. ValuEngine downgraded shares of Teleflex from a “buy” rating to a “hold” rating in a research note on Friday, December 1st. Deutsche Bank downgraded shares of Teleflex from a “buy” rating to a “hold” rating and set a $251.00 target price for the company. in a research note on Tuesday, November 14th. Piper Jaffray Companies started coverage on shares of Teleflex in a research note on Friday, November 10th. They issued an “overweight” rating and a $295.00 target price for the company. Morgan Stanley upped their target price on shares of Teleflex from $274.00 to $290.00 and gave the company an “equal weight” rating in a research note on Friday, November 3rd. Finally, Jefferies Group upped their target price on shares of Teleflex from $270.00 to $295.00 and gave the company a “buy” rating in a research note on Friday, November 3rd. One analyst has rated the stock with a sell rating, five have issued a hold rating and six have given a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and a consensus price target of $274.44.

In other Teleflex news, Director Stephen K. M.D. Klasko sold 200 shares of the stock in a transaction on Monday, October 2nd. The shares were sold at an average price of $241.88, for a total transaction of $48,376.00. Following the sale, the director now directly owns 8,080 shares of the company’s stock, valued at $1,954,390.40. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Benson Smith sold 2,000 shares of the stock in a transaction on Monday, December 4th. The stock was sold at an average price of $258.10, for a total transaction of $516,200.00. Following the sale, the chief executive officer now directly owns 76,634 shares in the company, valued at $19,779,235.40. The disclosure for this sale can be found here. Insiders have sold 2,600 shares of company stock worth $665,076 over the last three months. 2.39% of the stock is owned by corporate insiders.

Teleflex Incorporated (NYSE TFX) traded up $2.82 on Monday, reaching $252.17. 657,900 shares of the company traded hands, compared to its average volume of 264,938. The firm has a market capitalization of $11,360.01, a PE ratio of 31.17, a PEG ratio of 2.16 and a beta of 1.09. The company has a quick ratio of 3.70, a current ratio of 4.72 and a debt-to-equity ratio of 0.88. Teleflex Incorporated has a 1 year low of $155.47 and a 1 year high of $271.23.

Teleflex (NYSE:TFX) last issued its earnings results on Thursday, November 2nd. The medical technology company reported $2.12 earnings per share for the quarter, topping the Zacks’ consensus estimate of $2.01 by $0.11. The company had revenue of $534.70 million for the quarter, compared to analysts’ expectations of $522.94 million. Teleflex had a net margin of 12.41% and a return on equity of 16.27%. The firm’s revenue was up 17.3% compared to the same quarter last year. During the same period in the prior year, the company earned $1.80 earnings per share. sell-side analysts predict that Teleflex Incorporated will post 8.35 earnings per share for the current year.

The firm also recently announced a quarterly dividend, which was paid on Friday, December 15th. Shareholders of record on Wednesday, November 15th were issued a dividend of $0.34 per share. The ex-dividend date was Tuesday, November 14th. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.54%. Teleflex’s dividend payout ratio (DPR) is 24.82%.

TRADEMARK VIOLATION NOTICE: “1,398 Shares in Teleflex Incorporated (TFX) Acquired by IFM Investors Pty Ltd” was reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this piece on another publication, it was illegally copied and reposted in violation of US & international trademark and copyright legislation. The legal version of this piece can be read at https://www.thecerbatgem.com/2017/12/18/1398-shares-in-teleflex-incorporated-tfx-acquired-by-ifm-investors-pty-ltd.html.

About Teleflex

Teleflex Incorporated is a provider of medical technology products. The Company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for diagnostic and therapeutic procedures in critical care and surgical applications. The Company operates through six segments: Vascular North America; Anesthesia North America; Surgical North America; Europe, the Middle East and Africa (EMEA); Asia, and Original Equipment Manufacturer (OEM).

Want to see what other hedge funds are holding TFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teleflex Incorporated (NYSE:TFX).

Institutional Ownership by Quarter for Teleflex (NYSE:TFX)

Receive News & Stock Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related stocks with our FREE daily email newsletter.